Nine normal volunteer subjects (6 males and 3 females), nineteen to thirty-six years of age, and 5 patients with primary aldosteronism (3 females and 2 males), forty to fifty-two years of age, were ...

Subjects came from the slow adverse vascular effects of excess weight study (SAVE), a randomized-controlled trial (NCT00366990) evaluating the effects of weight loss, increased physical activity and ...

IT has been shown 1 that during a prolonged stay at altitudes above 15,000 ft. there is an increase in the salivary excretion of sodium and a decrease in that of potassium. In one subject this change ...

Over time, the retention of sodium leads to crackles, peripheral edema, hepatomegaly with ascites, increased blood volume, and increased cardiac filling pressures. Although diuretics do not directly ...

Higher serum aldosterone levels among patients with chronic kidney disease (CKD) are independently associated with an increased risk for CKD progression and end-stage kidney disease (ESKD) regardless ...

E.D., a 40-year-old man, was first noted to have an elevated blood pressure (240/140) during an insurance examination in January, 1966. The blood pressure was known to have been normal in 1945. In the ...

One of the functions of your adrenal glands is to produce a hormone called aldosterone that plays an active role in your blood pressure. It does this by maintaining the balance of sodium, potassium, ...

Aldosterone is a hormone that helps regulate sodium and potassium levels in the blood. Hyperaldosteronism and hypoaldosteronism are conditions involving abnormal aldosterone levels. The adrenal glands ...

Aldosterone antagonists (spironolactone, eplerenone) also known as “potassium sparing diuretics” block the action of aldosterone inhibiting the reuptake of sodium and water. Normally, when sodium ...

A drug that has been used to slow progression of kidney and cardiovascular disease in people with type 2 diabetes may also help people with chronic kidney disease who do not have diabetes, according ...